Practice with national-level exam (FACT, FACT Plus, NET, CUET, etc.) mocks, learn from structured notes, and get your doubts solved in one place.
How microbial sequencing built the case in Amerithrax: the morphotype variants of Bacillus anthracis Ames strain, the FBI-USAMRIID investigation, whole-genome sequencing-based attribution, the post-2001 build-out of the National Bioforensic Analysis Center, and the COVID-19-era sequencing capacity that put microbial forensics on every public-health agenda.
Last updated:
On 18 September 2001, letters postmarked from Trenton, New Jersey, began arriving at news media offices in New York and Florida. Three weeks later, a second wave of letters addressed to Democratic senators Tom Daschle and Patrick Leahy left the same Trenton post office. By early November, 22 people had been infected with anthrax and five had died of inhalation anthrax, including postal workers at the Brentwood mail-processing facility in Washington DC. The federal investigation that followed, codenamed Amerithrax, ran for seven years, involved the US Federal Bureau of Investigation, the US Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland, and dozens of academic microbiologists, and ultimately attributed the attacks to a single scientist working in USAMRIID's anthrax vaccine programme. What allowed investigators to reach that conclusion, and to survive intense scientific peer review, was a new forensic discipline built almost entirely during the investigation: microbial forensics.
Microbial forensics is the application of molecular biology, genomics, and population genetics to questions of origin and attribution in cases involving microorganisms, toxins, or other biological agents that cause harm or that are suspected of intentional misuse. Its foundational challenge is that microorganisms reproduce clonally by default, meaning that a flask of Bacillus anthracis Ames strain contains millions of organisms that are for practical purposes genetically identical to each other and to any other preparation of the same strain. The analytical task is therefore to find the genetic variation that does exist within a strain population, characterise it, and use it to connect a specific sample to a specific preparation and, ultimately, a specific laboratory.
The post-Amerithrax decade saw substantial institutional investment in this capacity. The US National Bioforensic Analysis Center (NBFAC) was established at Fort Detrick in 2004 as the primary bioforensics reference laboratory for the federal government. The UK's Health Security Agency (UKHSA, formerly Public Health England) maintains parallel capability at Porton Down. The Institut Pasteur in Paris and the Robert Koch Institut in Berlin hold reference collections and sequencing capacity for bacterial and viral agents relevant to bioterrorism scenarios. The COVID-19 pandemic, which required global real-time whole-genome sequencing of SARS-CoV-2 to track variant emergence, demonstrated that the infrastructure for microbial genomics forensics had become a permanent feature of public-health response, not only a counter-terrorism capability.
Test yourself on Forensic Biotechnology with free, timed mocks.
Practice Forensic Biotechnology questionsThe breakthrough in Amerithrax was not a DNA sequencer, it was a technician noticing that one flask of anthrax had colonies of four slightly different shapes growing on blood agar, when all previous microbiology said there should be only one.
Bacillus anthracis is a Gram-positive, spore-forming bacterium. Its two virulence plasmids, pXO1 (which encodes the tripartite anthrax toxin: protective antigen, lethal factor, and oedema factor) and pXO2 (which encodes the poly-D-glutamic acid capsule), distinguish it from closely related environmental Bacillus species including B. cereus and B. thuringiensis. All three share more than 99.5% 16S rRNA sequence identity. Identification of B. anthracis in a clinical or forensic context therefore requires either detection of the plasmid-encoded virulence genes by PCR (pXO1: lef, cya, pag; pXO2: capB) or whole-genome sequencing, not 16S rRNA alone.
The Ames strain of B. anthracis was isolated from a dead Texas cow in 1981 and became the primary strain used in US biodefence vaccine research because it is highly virulent in animal challenge models. By 2001 it was held at multiple biodefence laboratories. Because the Ames strain was thought to be genetically uniform, the initial assumption was that tracing the letters' material to a specific preparation would be impossible.
The breakthrough came from Patricia Worsham and colleagues at USAMRIID, who, while characterising the letters' spore preparations, noticed that cultures from the Daschle letter contained four distinct colony morphologies (morphotypes) on blood agar that were not present in the reference Ames Ancestor strain. These morphotypes, designated A, B, C, and D, differed in colony appearance due to spontaneous mutations that had arisen and been co-selected or co-maintained during specific laboratory passage history. The presence of all four morphotypes in the letters' preparation, at consistent proportions, became a microbial fingerprint. When investigators screened approximately 1,070 cultures held at laboratories that had received the Ames strain, only eight cultures contained all four morphotypes. All eight traced back to a single flask at USAMRIID, designated RMR-1029, maintained by the anthrax vaccine researcher Bruce Ivins.
When morphotype identification narrowed the source to RMR-1029, the FBI assembled a consortium of academic laboratories to validate the finding by whole-genome sequencing, because the legal standard required more than one laboratory's opinion.
Validating the morphotype finding required an independent genomic approach. A consortium of academic and government laboratories, coordinated by the FBI's Weapons of Mass Destruction Directorate, performed whole-genome sequencing of the four morphotype variants isolated from the letters and compared them to the Ames Ancestor reference genome (GenBank accession AE017334) and to the RMR-1029-derived cultures.
The sequencing work identified single-nucleotide polymorphisms (SNPs) specific to each morphotype variant. These SNPs arose as somatic mutations during bacterial growth and were maintained as minority variants in the mixed RMR-1029 population. Because the mutations occurred independently (each morphotype arose by a different mutation event), finding all four in the letters' preparation simultaneously had a probability orders of magnitude lower than chance co-selection from any other Ames-strain preparation. The consortium's findings were subjected to external peer review and were considered sufficiently robust to support a criminal prosecution.
The genomic methodology used in Amerithrax was documented in a series of peer-reviewed publications, including a landmark paper in PNAS (Rasko et al., 2011), which was published after the FBI formally closed the case. The paper described how comparative genomics allowed the identification of strain-specific markers and validated the attribution approach. A subsequent National Academy of Sciences review (2011) endorsed the scientific soundness of the approach while noting that the interpretation of the statistical evidence against Ivins individually (who died in 2008 before trial) required care.
In the UK, the Defence Science and Technology Laboratory (Dstl) at Porton Down maintains a parallel whole-genome sequencing capability for biological threat agents. Porton Down contributed to the forensic investigation of the 2018 Salisbury Novichok poisoning, which, while a chemical rather than biological event, demonstrated that Dstl can produce forensic genomic evidence at the speed required for law enforcement response. In Germany, the Robert Koch Institut manages BNI-level-4 biosafety laboratory capacity for biothreat agent characterisation and has been formally integrated into Germany's biosecurity response planning through the Federal Office for Civil Protection and Disaster Assistance (BBK).
Amerithrax demonstrated that the US had no institution whose sole mission was applying forensic standards to biological evidence, the NBFAC was the answer, and it took five years from the attacks to full operational capability.
The US National Bioforensic Analysis Center was established at Fort Detrick in 2004, initially housed within the National Interagency Biodefense Campus alongside USAMRIID and other agencies. It is operated by the Department of Homeland Security and provides forensic analytical support to federal law enforcement for cases involving biological agents potentially used in criminal or terrorist acts. Unlike a traditional forensic laboratory that receives physical evidence items and processes them through a standard menu of tests, the NBFAC maintains standing analytical capacity for select agents (as defined under the US Select Agent Program, 42 CFR Part 73) and provides scientific testimony in prosecutions.
NBFAC's methodology for biological evidence analysis draws directly on the lessons of Amerithrax. Microbial forensic analysis of an unknown spore or bacterial preparation now includes: a morphological characterisation under biosafety level 3 or 4 containment; multi-locus sequence typing (MLST) using five to seven housekeeping gene loci to place the isolate on a species-level tree; whole-genome sequencing to identify strain-specific SNPs, insertions/deletions, and plasmid content; comparison against a curated reference database of known strains from legitimate research and biodefence programmes; and statistical assessment of the probability that the seized preparation was derived from a specific source preparation.
The UK UKHSA maintains the National Bioterrorism Laboratory Network, coordinated through Porton Down, with four designated bioterrorism reference laboratories at NHS trusts. These laboratories operate under the National Infection Service framework and provide rapid diagnostic support (including whole-genome sequencing) for biological incidents. Their forensic reporting runs through established police-laboratory liaison channels and feeds into Crown Prosecution Service case files.
In India, the biosafety and bioforensics infrastructure is less centralised. The National Institute of Communicable Diseases (NCDC, New Delhi) and the National Centre for Disease Control (NCDC, part of the same complex) carry clinical reference capacity for dangerous pathogens. The Defence Research and Development Organisation (DRDO) maintains biodefence-relevant capability at the Defence Research and Development Establishment (DRDE) in Gwalior. Institutional coordination for a suspected biothreat event would run through the Ministry of Home Affairs crisis-management framework and through the National Disaster Management Authority, rather than through a single dedicated bioforensics laboratory.
The pandemic demonstrated that the global infrastructure for real-time pathogen whole-genome sequencing had grown from a counter-terrorism niche to a mainstream public-health instrument, and it brought the question of pathogen origin attribution back to the centre of geopolitical and forensic debate.
The SARS-CoV-2 pandemic required the rapid establishment of global sequencing networks at a scale never previously attempted. The GISAID (Global Initiative on Sharing Avian Influenza Data) database, established in 2008 for influenza genomics, became the primary repository for SARS-CoV-2 sequences, holding over 15 million submissions by 2023 from laboratories on every inhabited continent. In the UK, the COVID-19 Genomics UK Consortium (COG-UK) sequenced over 300,000 SARS-CoV-2 genomes in its first year of operation, providing the sequencing backbone for the identification of the Alpha and Delta variants and informing national policy on border restrictions and vaccine deployment. In India, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) coordinated sequencing from 54 laboratories and contributed to WHO variant-of-concern designations.
This sequencing infrastructure has direct relevance to forensic microbiology. Phylogenetic analysis of SARS-CoV-2 sequences was used in a UK coroner inquest in 2021 to estimate the likely source of a healthcare worker's infection, using BEAST (Bayesian Evolutionary Analysis Sampling Trees) phylogenetics to compare the worker's viral sequence with contemporaneous sequences from patients in the same clinical environment. This represented one of the first uses of SARS-CoV-2 genomics in a medico-legal context beyond epidemiology.
The question of pathogen origin for SARS-CoV-2 itself illustrates the epistemic limits of forensic microbial attribution. Investigations by the WHO-convened Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) and by US intelligence agencies produced divergent confidence assessments on the natural spillover versus laboratory-leak hypotheses. The forensic standard relevant to criminal attribution, beyond reasonable doubt, was not met by the available genomic evidence, illustrating a central lesson of microbial forensics: molecular data can narrow attribution to a population of possible sources but cannot always resolve attribution to a single source without corroborating non-molecular evidence. This was true in Amerithrax (where non-molecular evidence pointed to Ivins independently of the genomic findings) and remains true for any novel-pathogen origin investigation.
In the Amerithrax investigation, the letters' spore preparation contained four morphotype variants of Bacillus anthracis Ames strain. Why was the presence of all four variants significant for attribution?